Cargando…
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
BACKGROUND: Current studies on adherence to endocrine therapy in breast cancer patients suffer from methodological limitations due to a lack of well-validated methods for assessing adherence. There is no gold standard for measuring adherence. The aim of our study was to compare four different approa...
Autores principales: | Oberguggenberger, Anne S, Sztankay, Monika, Beer, Beate, Schubert, Birthe, Meraner, Verena, Oberacher, Herbert, Kemmler, Georg, Giesinger, Johannes, Gamper, Eva, Sperner-Unterweger, Barbara, Marth, Christian, Holzner, Bernhard, Hubalek, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519669/ https://www.ncbi.nlm.nih.gov/pubmed/23066928 http://dx.doi.org/10.1186/1471-2407-12-474 |
Ejemplares similares
-
Can we use gonadotropin plasma concentration as surrogate marker for BMI-related incomplete estrogen suppression in breast cancer patients receiving anastrozole?
por: Oberguggenberger, A., et al.
Publicado: (2017) -
Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study
por: Oberguggenberger, Anne, et al.
Publicado: (2017) -
Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival
por: Carmen, Albertini, et al.
Publicado: (2022) -
Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy
por: Meraner, Verena, et al.
Publicado: (2012) -
Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
por: Giesinger, Johannes M, et al.
Publicado: (2014)